Atsushi Hokari

585 total citations
28 papers, 430 citations indexed

About

Atsushi Hokari is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Atsushi Hokari has authored 28 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Atsushi Hokari's work include Liver Disease Diagnosis and Treatment (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Liver Diseases and Immunity (5 papers). Atsushi Hokari is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Liver Diseases and Immunity (5 papers). Atsushi Hokari collaborates with scholars based in Japan, United States and United Kingdom. Atsushi Hokari's co-authors include Hiroyasu Esumi, Yoshio Aizawa, Mikio Zeniya, Hisao Tajiri, Tomohisa Ishikawa, Tsutomu Ogura, Alessandro Weisz, Junkoh Yamashita, Noritomo Shimada and Daisuke Endo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Neurochemistry and Medicine.

In The Last Decade

Atsushi Hokari

22 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsushi Hokari Japan 11 152 143 114 73 66 28 430
Marta Duran‐Güell Spain 14 166 1.1× 271 1.9× 81 0.7× 32 0.4× 151 2.3× 20 558
Roger Flores‐Costa Spain 13 159 1.0× 264 1.8× 85 0.7× 29 0.4× 168 2.5× 19 581
Trinidad Parra Spain 8 81 0.5× 54 0.4× 82 0.7× 26 0.4× 89 1.3× 10 391
H Moriwaki Japan 10 290 1.9× 331 2.3× 111 1.0× 40 0.5× 187 2.8× 22 664
Bing Du China 13 60 0.4× 136 1.0× 44 0.4× 31 0.4× 150 2.3× 29 504
Urszula Osinska Warncke United States 9 87 0.6× 311 2.2× 122 1.1× 28 0.4× 143 2.2× 11 523
Yoshiyasu Shinohara Japan 11 129 0.8× 451 3.2× 139 1.2× 41 0.6× 217 3.3× 18 665
Nobuhito Taniki Japan 14 223 1.5× 286 2.0× 50 0.4× 52 0.7× 131 2.0× 43 589
Muhammad Amir Pakistan 6 73 0.5× 385 2.7× 66 0.6× 40 0.5× 159 2.4× 23 541
Isabel Veloso Alves Pereira Brazil 16 100 0.7× 250 1.7× 84 0.7× 50 0.7× 322 4.9× 34 601

Countries citing papers authored by Atsushi Hokari

Since Specialization
Citations

This map shows the geographic impact of Atsushi Hokari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Hokari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Hokari more than expected).

Fields of papers citing papers by Atsushi Hokari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Hokari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Hokari. The network helps show where Atsushi Hokari may publish in the future.

Co-authorship network of co-authors of Atsushi Hokari

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Hokari. A scholar is included among the top collaborators of Atsushi Hokari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Hokari. Atsushi Hokari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arihiro, Seiji, Yoji Ogasawara, Masayuki Kato, et al.. (2023). A rare case of Epstein–Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis. Clinical Journal of Gastroenterology. 16(4). 543–549.
2.
3.
Ando, Yukio, Daisuke Endo, Hiroshi Yokoyama, et al.. (2021). Contribution of Capsule Endoscopy Early in a Bleeding Episode to Treatment of Small Bowel Angioectasia: A Case Report. Medicina. 57(4). 321–321. 1 indexed citations
4.
Ando, Yukio, Daisuke Endo, Hiroshi Yokoyama, et al.. (2020). Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report. Clinical Journal of Gastroenterology. 14(2). 696–696.
5.
Ishikawa, Tomohisa, et al.. (2020). The Molar Ratio of Total Branched-chain Amino Acids to Tyrosine Predicts a Digit Symbol Test Abnormality in Cirrhotic Patients. Internal Medicine. 59(14). 1695–1704. 2 indexed citations
6.
Ito, Zensho, Shin Kan, Sankichi Horiuchi, et al.. (2019). Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. Oncology. 97(3). 135–148. 10 indexed citations
7.
Arihiro, Seiji, Akio Nakashima, Kan Uchiyama, et al.. (2019). Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 25(6). 1088–1095. 75 indexed citations
8.
Torisu, Yuichi, Keiko Takano, Ryo Nakagawa, et al.. (2017). Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis. World Journal of Hepatology. 9(1). 57–57. 8 indexed citations
9.
Endo, Daisuke, et al.. (2017). Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b. World Journal of Gastroenterology. 23(13). 2355–2355. 40 indexed citations
10.
Aizawa, Yoshio & Atsushi Hokari. (2017). Autoimmune hepatitis: current challenges and future prospects. Clinical and Experimental Gastroenterology. Volume 10. 9–18. 39 indexed citations
11.
Hokari, Atsushi. (2012). Efficacy of MK615 for the treatment of patients with liver disorders. World Journal of Gastroenterology. 18(31). 4118–4118. 16 indexed citations
12.
Iwaku, Akira, et al.. (2010). Successful hepatic arterial infusion chemotherapy of cisplatin in hepatocellular carcinoma. Kanzo. 51(1). 21–27. 1 indexed citations
13.
Zeniya, Mikio, Keitaro Yokoyama, Tomohisa Ishikawa, et al.. (2010). Significance of interferon‐β for the treatment of hepatitis C virus infection in hemodialyzed patients. Hepatology Research. 40(9). 862–869. 4 indexed citations
14.
Oikawa, Tsunekazu, Hiroki Takahashi, Tomohisa Ishikawa, et al.. (2007). Intrahepatic expression of the co‐stimulatory molecules programmed death‐1, and its ligands in autoimmune liver disease. Pathology International. 57(8). 485–492. 48 indexed citations
15.
Hokari, Atsushi, et al.. (2005). Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C. Journal of Infection. 51(1). 47–53. 11 indexed citations
16.
Hokari, Atsushi, et al.. (2002). Detection of serum nitrite and nitrate in primary biliary cirrhosis: Possible role of nitric oxide in bile duct injury. Journal of Gastroenterology and Hepatology. 17(3). 308–315. 31 indexed citations
17.
Zeniya, Mikio, Hiroshi Abe, Kazuhiko Koike, et al.. (1997). The evaluation of autoimmune hepatitis(AIH) scoring system for the therapy choice to patients with autoimmune hepatitis.. Kanzo. 38(11). 646–653. 1 indexed citations
18.
19.
Fujisawa, Hironori, Tsutomu Ogura, Atsushi Hokari, et al.. (1995). Inducible Nitric Oxide Synthase in a Human Glioblastoma Cell Line. Journal of Neurochemistry. 64(1). 85–91. 50 indexed citations
20.
Esumi, Hiroyasu, et al.. (1995). Implication of nitric oxide synthase in carcinogenesis: analysis of the human inducible nitric oxide synthase gene. Pharmacogenetics. 5(Special Issue). S166–S170. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Duran‐Güell Breakdown of academic impact, for papers by Roger Flores‐Costa Breakdown of academic impact, for papers by Trinidad Parra Breakdown of academic impact, for papers by H Moriwaki Breakdown of academic impact, for papers by Bing Du Breakdown of academic impact, for papers by Urszula Osinska Warncke Breakdown of academic impact, for papers by Yoshiyasu Shinohara Breakdown of academic impact, for papers by Nobuhito Taniki Breakdown of academic impact, for papers by Muhammad Amir Breakdown of academic impact, for papers by Isabel Veloso Alves Pereira
Rankless by CCL
2026